Caspofungin for the Treatment of Pediatric Fungal Infections
暂无分享,去创建一个
[1] Max E Valentinuzzi,et al. SAFETY AND EFFICACY , 2010 .
[2] Russell E. Lewis,et al. Caspofungin-mediated beta-glucan unmasking and enhancement of human polymorphonuclear neutrophil activity against Aspergillus and non-Aspergillus hyphae. , 2008, The Journal of infectious diseases.
[3] F. Locatelli,et al. Bmc Infectious Diseases Safety and Efficacy of a Caspofungin-based Combination Therapy for Treatment of Proven or Probable Aspergillosis in Pediatric Hematological Patients , 2022 .
[4] M. Pfaller,et al. In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance , 2006, Journal of Clinical Microbiology.
[5] A. Shad,et al. Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents , 2005, Antimicrobial Agents and Chemotherapy.
[6] M. J. Buitrago,et al. Combined Activity In Vitro of Caspofungin, Amphotericin B, and Azole Agents against Itraconazole-Resistant Clinical Isolates of Aspergillus fumigatus , 2005, Antimicrobial Agents and Chemotherapy.
[7] T. Walsh,et al. New agents for invasive mycoses in children , 2005, Current opinion in pediatrics.
[8] H. Möller,et al. Zotepine Versus Placebo in the Treatment of Schizophrenic Patients with Stable Primary Negative Symptoms: A Randomized Double-Blind Multicenter Trial , 2004, Pharmacopsychiatry.
[9] A. Sterrett,et al. Single- and Multiple-Dose Pharmacokinetics of Caspofungin in Healthy Men , 2002, Antimicrobial Agents and Chemotherapy.
[10] T. Zaoutis,et al. Treatment of Invasive Candidiasis in Immunocompromised Pediatric Patients , 2008, Paediatric drugs.